Xin Wang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 40

Top Topics

Chronic Lymphocytic Leukemia

Histone Deacetylase

Diffuse Large B Cell Lymphoma

Top Venues

Cancer communications (London, England)

Journal of molecular medicine (Berlin, Germany)

Cell death discovery

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Mengfei Ding, Zhuoya Yu, Tiange Lu, Shunfeng Hu, Xiangxiang Zhou, Xin Wang
N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Clinical and translational medicine 14 (7) (2024)
Wenyue Sun, Shunfeng Hu, Xin Wang
Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies. Cancer communications (London, England) (2024)
Qiqi Qiao, Shunfeng Hu, Xin Wang
The regulatory roles and clinical significance of glycolysis in tumor. Cancer communications (London, England) (2024)
Mengfei Ding, Zhuoya Yu, Tiange Lu, Shunfeng Hu, Xiangxiang Zhou, Xin Wang
N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Clinical and translational medicine 14 (7) (2024)
Qiqi Qiao, Shunfeng Hu, Xin Wang
The regulatory roles and clinical significance of glycolysis in tumor. Cancer communications (London, England) 44 (7) (2024)
Mengyuan He, Xiangxiang Zhou, Xin Wang
Glycosylation: mechanisms, biological functions and clinical implications. Signal transduction and targeted therapy 9 (1) (2024)
Junyun Yuan, Ya Zhang, Xin Wang
Application of machine learning in the management of lymphoma: Current practice and future prospects. Digital health 10 (2024)
Junyun Yuan, Ya Zhang, Xin Wang
Application of machine learning in the management of lymphoma: Current practice and future prospects. Digital health 10 (2024)
Weiyi Yao, Xinting Hu, Xin Wang
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases. Signal transduction and targeted therapy 9 (1) (2024)
Qiqi Qiao, Shunfeng Hu, Xin Wang
The regulatory roles and clinical significance of glycolysis in tumor. Cancer communications (London, England) 44 (7) (2024)
Mengyuan He, Xiangxiang Zhou, Xin Wang
Glycosylation: mechanisms, biological functions and clinical implications. Signal transduction and targeted therapy 9 (1) (2024)
Mengfei Ding, Zhuoya Yu, Tiange Lu, Shunfeng Hu, Xiangxiang Zhou, Xin Wang
N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Clinical and translational medicine 14 (7) (2024)
Junyun Yuan, Ya Zhang, Xin Wang
Application of machine learning in the management of lymphoma: Current practice and future prospects. Digital health 10 (2024)
Qiqi Qiao, Shunfeng Hu, Xin Wang
The regulatory roles and clinical significance of glycolysis in tumor. Cancer communications (London, England) 44 (7) (2024)
Qiqi Qiao, Shunfeng Hu, Xin Wang
The regulatory roles and clinical significance of glycolysis in tumor. Cancer communications (London, England) 44 (7) (2024)
Mengyuan He, Xiangxiang Zhou, Xin Wang
Glycosylation: mechanisms, biological functions and clinical implications. Signal transduction and targeted therapy 9 (1) (2024)
Mengfei Ding, Zhuoya Yu, Tiange Lu, Shunfeng Hu, Xiangxiang Zhou, Xin Wang
N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Clinical and translational medicine 14 (7) (2024)
Xin Zhang, Yang Han, Yu Nie, Yujie Jiang, Xiaohui Sui, Xueling Ge, Fang Liu, Ya Zhang, Xin Wang
PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. Journal of molecular medicine (Berlin, Germany) (2023)
Shunfeng Hu, Tiange Lu, Juanjuan Shang, Yiqing Cai, Mengfei Ding, Xiangxiang Zhou, Xin Wang
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations. Cell death discovery 9 (1) (2023)
Shunfeng Hu, Tiange Lu, Juanjuan Shang, Yiqing Cai, Mengfei Ding, Xiangxiang Zhou, Xin Wang
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations. Cell death discovery 9 (1) (2023)
Shunfeng Hu, Tiange Lu, Juanjuan Shang, Yiqing Cai, Mengfei Ding, Xiangxiang Zhou, Xin Wang
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations. Cell death discovery 9 (1) (2023)
Yurou Chu, Yingyue Liu, Zhuoya Yu, Linquan Zhan, Tiange Lu, Yujie Jiang, Xiaosheng Fang, Xiangxiang Zhou, Xin Wang
Maintenance and consolidation strategies for patients with untreated advanced follicular lymphoma: A systematic review and network meta-analysis of randomized trials. Cancer (2023)
Xin Zhang, Yang Han, Yu Nie, Yujie Jiang, Xiaohui Sui, Xueling Ge, Fang Liu, Ya Zhang, Xin Wang
PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. Journal of molecular medicine (Berlin, Germany) 101 (5) (2023)
Yiqing Cai, Liemei Lv, Tiange Lu, Mengfei Ding, Zhuoya Yu, Xiaomin Chen, Xiangxiang Zhou, Xin Wang
α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis. Cell death discovery 9 (1) (2023)
Xin Zhang, Yang Han, Yu Nie, Yujie Jiang, Xiaohui Sui, Xueling Ge, Fang Liu, Ya Zhang, Xin Wang
PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. Journal of molecular medicine (Berlin, Germany) 101 (5) (2023)
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Han Yan, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zunmin Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Renbin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study. Blood advances (2023)
Xin Zhang, Yang Han, Yu Nie, Yujie Jiang, Xiaohui Sui, Xueling Ge, Fang Liu, Ya Zhang, Xin Wang
PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. Journal of molecular medicine (Berlin, Germany) 101 (5) (2023)
Yurou Chu, Yingyue Liu, Yujie Jiang, Xueling Ge, Dai Yuan, Mei Ding, Huiting Qu, Fang Liu, Xiangxiang Zhou, Xin Wang
Prognosis and complications of patients with primary gastrointestinal diffuse large B-cell lymphoma: Development and validation of the systemic inflammation response index-covered score. Cancer medicine (2023)
Shan Chong, Peng Zhao, Rui-Bin Huang, Hu Zhou, Jia-Ning Zhang, Ming Hou, Yi Liu, Hong-Xia Yao, Ting Niu, Jun Peng, Ming Jiang, Yan-Qiu Han, Jian-Da Hu, Ze-Ping Zhou, Lin Qiu, Lian-Sheng Zhang, Xin Wang, Hua-Quan Wang, Ru Feng, Lin-Hua Yang, Liang-Ming Ma, Shun-Qing Wang, Pei-Yan Kong, Wen-Sheng Wang, Hui-Ping Sun, Jing Sun, He-Bing Zhou, Tie-Nan Zhu, Li-Ru Wang, Jing-Yu Zhang, Qiu-Sha Huang, Hai-Xia Fu, Ye-Jun Wu, Yue-Ying Li, Qian-Fei Wang, Qian Jiang, Hao Jiang, Jin Lu, Xiao-Jun Huang, Xiao-Hui Zhang
Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study. Blood advances 6 (14) (2022)
Zhuoya Yu, Xiangxiang Zhou, Xin Wang
Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives. Cancer research 82 (17) (2022)
Xiao-Dong Mo, Shen-Da Hong, Yan-Li Zhao, Er-Lie Jiang, Jing Chen, Yang Xu, Zi-Min Sun, Wei-Jie Zhang, Qi-Fa Liu, Dai-Hong Liu, Ding-Ming Wan, Wen-Jian Mo, Han-Yun Ren, Ting Yang, He Huang, Xi Zhang, Xiao-Ning Wang, Xian-Min Song, Su-Jun Gao, Xin Wang, Yi Chen, Bing Xu, Ming Jiang, Xiao-Bing Huang, Xin Li, Hong-Yu Zhang, Hong-Tao Wang, Zhao Wang, Ting Niu, Ji-Shi Wang, Ling-Hui Xia, Xiao-Dan Liu, Fei Li, Fang Zhou, Tao Lang, Jiong Hu, Sui-Jing Wu, Xiao-Jun Huang
Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis. American journal of hematology 97 (4) (2022)
Tan Sang, Juan Yang, Jiarui Liu, Yang Han, Ying Li, Xiangxiang Zhou, Xin Wang
AMOT suppresses tumor progression via regulating DNA damage response signaling in diffuse large B-cell lymphoma. Cancer gene therapy 28 (10-11) (2021)
Yi Zhao, Juan Yang, Jiarui Liu, Yiqing Cai, Yang Han, Shunfeng Hu, Shuai Ren, Xiangxiang Zhou, Xin Wang
Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma. Cell death & disease 12 (7) (2021)
Yang Han, Xinting Hu, Xiaoya Yun, Jiarui Liu, Juan Yang, Zheng Tian, Xin Zhang, Ya Zhang, Xin Wang
Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51. Cell death & disease 12 (11) (2021)
Shunfeng Hu, Shuai Ren, Yiqing Cai, Jiarui Liu, Yang Han, Yi Zhao, Juan Yang, Xiangxiang Zhou, Xin Wang
Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling. Cell death and differentiation (2021)
Shunfeng Hu, Na Chen, Kang Lu, Changqing Zhen, Xiaohui Sui, Xiaosheng Fang, Ying Li, Yingshu Luo, Xiangxiang Zhou, Xin Wang
The prognostic roles of hepatitis B virus antibody in diffuse large B-cell lymphoma patients. Leukemia & lymphoma 62 (6) (2021)
Na Wang, Hongzhi Xu, Qing Li, Xiaosheng Fang, Jie Liu, Xiaohui Sui, Lingyan Zhang, Yujie Jiang, Xin Wang
Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data. Cancer management and research 12 (2020)
Xueling Ge, Wei Jiang, Yujie Jiang, Xiao Lv, Xin Liu, Xin Wang
Expression and Importance of TMED2 in Multiple Myeloma Cells. Cancer management and research 12 (2020)
Ying Li, Xiangxiang Zhou, Ya Zhang, Juan Yang, Yangyang Xu, Yi Zhao, Xin Wang
CUL4B regulates autophagy via JNK signaling in diffuse large B-cell lymphoma. Cell cycle (Georgetown, Tex.) 18 (4) (2019)
Mingyang Wang, Xiaosheng Fang, Xin Wang
Emerging role of histone deacetylase inhibitors in the treatment of diffuse large B-cell lymphoma. Leukemia & lymphoma 61 (4) (2019)